Homology Medicines Balance Sheet Health
Financial Health criteria checks 4/6
Homology Medicines has a total shareholder equity of $73.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $84.6M and $11.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$82.65m |
| Equity | US$72.99m |
| Total liabilities | US$11.57m |
| Total assets | US$84.56m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 35H's short term assets ($83.9M) exceed its short term liabilities ($11.6M).
Long Term Liabilities: 35H has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 35H is debt free.
Reducing Debt: 35H has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 35H has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 35H has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.2% each year